Exact Mass: 243.1174

Exact Mass Matches: 243.1174

Found 500 metabolites which its exact mass value is equals to given mass value 243.1174, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cytidine

4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

C9H13N3O5 (243.0855)


Cytidine is a nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose. Cytidine is a pyrimidine that besides being incorporated into nucleic acids, can serve as a substrate for the salvage pathway of pyrimidine nucleotide synthesis. It is a precursor of cytidine triphosphate (CTP) needed in the phosphatidylcholine (PC) and phosphatidylethanolamine (PE) biosynthetic pathways. These variations probably reflect the species differences in cytidine deaminase, the enzyme that converts cytidine to uridine in the body. The transport of cytidine into the brains extracellular fluid, and then into neurons and glia, are essential prerequisites for cytidine to be utilized in the brain. An efficient mechanism mediating the brain uptake of circulating cytidine has not yet been demonstrated. The biosynthesis of PC, the most abundant phosphatide in the brain, via the Kennedy pathway requires phosphocholine and cytidine triphosphate (CTP), a cytidine nucleotide involved in the rate-limiting step. The enzyme that converts CTP to endogenous CDP-choline (CTP:phosphocholine cytidylyltransferase) is unsaturated at physiological brain CTP levels. APOBEC is a family of enzymes that has been discovered with the ability to deaminate cytidines on RNA or DNA. The human apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G protein (APOBEC3G, or hA3G), provides cells with an intracellular antiretroviral activity that is associated with the hypermutation of viral DNA through cytidine deamination. Indeed, hA3G belongs to a family of vertebrate proteins that contains one or two copies of a signature sequence motif unique to cytidine deaminases (CTDAs) (PMID: 16769123, 15780864, 16720547). Cytidine is a nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose. Cytidine is a pyrimidine that besides being incorporated into nucleic acids, can serve as substrate for the salvage pathway of pyrimidine nucleotide synthesis; as precursor of the cytidine triphosphate (CTP) needed in the phosphatidylcholine (PC) and phosphatidylethanolamine (PE) biosynthetic pathway. These variations probably reflect the species differences in cytidine deaminase, the enzyme that converts cytidine to uridine in the body. The transports of cytidine into the brains extracellular fluid, and then into neurons and glia, are essential prerequisites for cytidine to be utilized in brain. An efficient mechanism mediating the brain uptake of circulating cytidine has not yet been demonstrated. The biosynthesis of PC, the most abundant phosphatide in the brain, via the Kennedy pathway requires phosphocholine and cytidine triphosphate (CTP), a cytidine nucleotide, which is involved in the rate-limiting step. The enzyme that converts CTP to endogenous CDP-choline (CTP: phosphocholine cytidylyltransferase) is unsaturated at physiological brain CTP levels. Cytidine is a white crystalline powder. (NTP, 1992) Cytidine is a pyrimidine nucleoside in which cytosine is attached to ribofuranose via a beta-N(1)-glycosidic bond. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is functionally related to a cytosine. Cytidine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Cytidine is a natural product found in Fritillaria thunbergii, Castanopsis fissa, and other organisms with data available. Cytidine is a pyrimidine nucleoside comprised of a cytosine bound to ribose via a beta-N1-glycosidic bond. Cytidine is a precursor for uridine. Both cytidine and uridine are utilized in RNA synthesis. Cytidine is a metabolite found in or produced by Saccharomyces cerevisiae. A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. A pyrimidine nucleoside in which cytosine is attached to ribofuranose via a beta-N(1)-glycosidic bond. [Spectral] Cytidine (exact mass = 243.08552) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) and NAD+ (exact mass = 663.10912) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Cytidine (exact mass = 243.08552) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Cytidine (exact mass = 243.08552) and S-Adenosyl-L-homocysteine (exact mass = 384.12159) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3]. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3]. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3].

   

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)octanamide

3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide

C12H21NO4 (243.1471)


   

Biotin amide

5-[(3AS,6R,6ar)-2-hydroxy-1H,3ah,4H,6H,6ah-thieno[3,4-D]imidazol-6-yl]pentanimidate

C10H17N3O2S (243.1041)


The enzyme biotinidase (EC-Number 3.5.1.12 ) is involved in the recycling of the vitamin biotin, cleaving D-biotinylamides and esters, in a reaction including biotin amide and water. (PMID 1719240, 171927). Late-onset multiple carboxylase deficiency (MCD) with biotinidase deficiency is caused by mutation in the biotinidase gene. MCD is an autosomal recessive metabolic disorder characterized primarily by cutaneous and neurologic abnormalities. Symptoms result from the patients inability to reutilize biotin, a necessary nutrient. (OMIM 253260). The enzyme biotinidase (EC-Number 3.5.1.12 ) is involved in the recycling of the vitamin biotin, cleaving D-biotinylamides and esters, in a reaction including biotin amide and water. (PMID 1719240, 171927)

   

gamma-Glutamyl-beta-cyanoalanine

(2S)-2-amino-4-{[(1S)-1-carboxy-2-cyanoethyl]-C-hydroxycarbonimidoyl}butanoic acid

C9H13N3O5 (243.0855)


This compound belongs to the family of N-acyl-Alpha Amino Acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).

   
   

Ipazine

6-chloro-N2,N2-diethyl-N4-(propan-2-yl)-1,3,5-triazine-2,4-diamine

C10H18ClN5 (243.1251)


   

2-amino-5-[1-(1H-indol-3-yl)ethyl]-1,3-oxazol-4-one

(5S)-2-amino-5-[(1R)-1-(1H-indol-3-yl)ethyl]-1,3-oxazol-4(5H)-one

C13H13N3O2 (243.1008)


   

Cytarabine

4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H13N3O5 (243.0855)


Cytarabine, or cytosine arabinoside, a pyrimidine nucleoside analog, is found in mushrooms. Cytarabine is isolated from the mushroom Xerocomus nigromaculatus of unknown palatability. Cytarabine is an antineoplastic anti-metabolite used in the treatment of several forms of leukemia including acute myelogenous leukemia and meningeal leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle to stop normal cell development and division. Cytarabine is metabolized intracellularly into its active triphosphate form (cytosine arabinoside triphosphate). This metabolite then damages DNA by multiple mechanisms, including the inhibition of alpha-DNA polymerase, inhibition of DNA repair through an effect on beta-DNA polymerase, and incorporation into DNA. The latter mechanism is probably the most important. Cytotoxicity is highly specific for the S phase of the cell cycle. Cytarabine is a chemotherapy agent used mainly in the treatment of hematological malignancies such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma. It is also known as ara C. Cytosine arabinoside is an antimetabolic agent with the chemical name of 1 -arabinofuranosylcytosine. Its mode of action is due to its rapid conversion into cytosine arabinoside triphosphate, which damages DNA when the cell cycle holds in the S phase (synthesis of DNA). Rapidly dividing cells, which require DNA replication for mitosis, are therefore most affected. Cytosine arabinoside also inhibits both DNA and RNA polymerases and nucleotide reductase enzymes needed for DNA synthesis L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites COVID info from COVID-19 Disease Map D000970 - Antineoplastic Agents KEIO_ID C119; [MS2] KO008896 KEIO_ID C119 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity. Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity.

   

Agomelatine

N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide

C15H17NO2 (243.1259)


Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. Agomelatine was discovered and developed by the European pharmaceutical company Servier Laboratories Ltd. Servier continue to develop the drug and conduct phase III trials in the European Union. In 2005 Servier submitted Agomelatine to the European Medicines Agency (EMEA). On 27 July 2006 the Committee for Medical Products for Human Use (CHMP) of the EMEA recommended a refusal of the marketing authorisation of Valdoxan/Thymanax. The major concern was that efficacy had not been sufficiently shown. In 2006 Servier sold the rights to develop Agomelatine in the US to Novartis. The development for the US market was discontinued in October 2011. It is currently sold in Australia under the Valdoxan trade name. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].

   

Prolyl-Glutamine

2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoate

C10H17N3O4 (243.1219)


Prolyl-Glutamine is a dipeptide composed of proline and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tiglylcarnitine

(3R)-3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


Tiglylcarnitine is an acylcarnitine. More specifically, it is an tiglic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Tiglylcarnitine is also detected in the urinary organic acid and blood spot acylcarnitine profiles in patients with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency, an inborn error of metabolism affecting isoleucine and ketone bodies in the catabolic process (PMID: 14518824 ). Tiglylcarnitine is found to be associated with celiac disease, which is also an inborn error of metabolism. Tiglylcarnitine has been identified in the human placenta (PMID: 32033212 ). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. Tiglylcarnitine is detected in the urinary organic acid and blood spot acylcarnitine profiles in patients with

   

Frovatriptan

(+)-(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate

C14H17N3O (243.1372)


Frovatriptan, also known as Frova (trade name), belongs to a class of medications known as 5-hydroxytryptamine agonists (triptan) (PMID: 18001261). It is widely indicated for the treatment of migraine headaches with or without aura in adults (PMID: 22900951, 27103792). It works in the brain to relieve migraine symptoms including headache, pain, nausea, vomiting, sensitivity to light/sound. However, it is not used to treat patients with hemiplegic, ophthalmoplegic or basilar migraine. Frovatriptan binds with high affinity for serotonin 5-HT1B and 5-HT1D receptors, thereby relieving pain by narrowing blood vessels (PMID: 11735616, 12517245). Patient’s may experience some side effects, especially who have heart or blood vessel disease. Frovatriptan is only found in individuals who have consumed or used this drug. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

Glutaminylproline

(2S)-1-[(2S)-2-Amino-4-(C-hydroxycarbonimidoyl)butanoyl]pyrrolidine-2-carboxylate

C10H17N3O4 (243.1219)


Glutaminylproline is a dipeptide composed of glutamine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Prolyl-Gamma-glutamate

2-Amino-4-[(pyrrolidine-2-carbonyl)-C-hydroxycarbonimidoyl]butanoate

C10H17N3O4 (243.1219)


Prolyl-Gamma-glutamate is a dipeptide composed of proline and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

2-Ethylacryloylcarnitine

3-[(2-methylidenebutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


2-Ethylacryloylcarnitine is an acylcarnitine. More specifically, it is an ethacrylic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylacryloylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-Ethylacryloylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Tiglylcarnitine

3-(pent-4-enoyloxy)-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


4-Tiglylcarnitine is an acylcarnitine. More specifically, it is an pent-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 4-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular 4-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3E)-Tiglylcarnitine

3-(pent-3-enoyloxy)-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


(3E)-Tiglylcarnitine is an acylcarnitine. More specifically, it is an (3E)-pent-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (3E)-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Tiglylcarnitine

3-(pent-2-enoyloxy)-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


2-Tiglylcarnitine is an acylcarnitine. More specifically, it is an pent-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular 2-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylbut-2-enoylcarnitine

3-[(3-methylbut-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


3-methylbut-2-enoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylbut-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-methylbut-2-enoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3-methylbut-2-enoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Arabinofuranosylcytosine

4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H13N3O5 (243.0855)


Isolated from the mushroom Xerocomus nigromaculatus of unknown palatability This compound has been identified in human blood as reported by (PMID: 31557052 ). Arabinofuranosylcytosine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Arabinofuranosylcytosine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. Arabinofuranosylcytosine (Ara-C), also known as cytarabine, is a chemotherapeutic agent that is widely used in the treatment of various types of cancer, particularly hematological malignancies such as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). The biological functions of Ara-C are primarily related to its antineoplastic properties, which are derived from its mechanism of action within the cell. Here is a detailed description of its biological functions: 1. **Inhibition of DNA Synthesis**: Ara-C functions as a nucleoside analog, which means it resembles the natural building blocks of DNA. Once inside the cell, Ara-C is converted to its active metabolite, araCTP (arabinofuranosylcytosine triphosphate). AraCTP competes with the natural deoxycytidine triphosphate (dCTP) for incorporation into the growing DNA chain during the S phase of the cell cycle. Because Ara-C lacks a 3'-hydroxyl group, its incorporation into DNA leads to chain termination, effectively stopping DNA synthesis. 2. **Cell Cycle Specificity**: Ara-C is most effective against cells that are actively dividing. Since it targets cells in the S phase of the cell cycle, it is particularly harmful to rapidly dividing cancer cells, which often spend a significant portion of their cycle in this phase. 3. **Inhibition of DNA Repair**: Beyond its direct effect on DNA synthesis, Ara-C can also interfere with DNA repair mechanisms. This is because the incorporation of Ara-C into DNA can cause mispairing and induce DNA damage, which the cell may be unable to repair properly. 4. **Cell Death Induction**: The inhibition of DNA synthesis and the induction of DNA damage can lead to cell death through apoptosis or necrosis. Cells that cannot replicate their DNA or repair the damage caused by Ara-C activation are programmed to die, which is a desirable outcome in the context of cancer treatment. 5. **Immune System Modulation**: In some cases, Ara-C can also modulate the immune system, although this is not its primary function. It can affect the function and proliferation of immune cells, which can have implications for both its therapeutic effects and side effects. 6. **Enzymatic Conversion**: Ara-C must be activated within the cell by the enzyme deoxycytidine kinase (dCK), which phosphorylates it to Ara-CMP (monophosphate), then to Ara-CDP (diphosphate), and finally to Ara-CTP. The efficiency of this conversion can vary between different types of cancer cells and normal cells, contributing to the selectivity of Ara-C's action. 7. **Cross-Linking Potential**: Although less common, Ara-C can also form cross-links with DNA, further complicating DNA structure and function, which can contribute to its cytotoxic effects. The biological functions of Ara-C are complex and can vary depending on the dose, the specific cancer type, and the individual patient's metabolism. Its use is carefully monitored in clinical settings due to its potential for significant side effects, including myelosuppression (decreased production of blood cells), gastrointestinal toxicity, and central nervous system toxicity.

   

Benzonaphthazepine

7-azatetracyclo[9.8.0.0^{2,8}.0^{14,19}]nonadeca-1(11),2(8),3,5,9,12,14,16,18-nonaene

C18H13N (243.1048)


   

N-Methyl-2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-5-amine

N-Methyl-2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-5-amine

C11H12F3N3 (243.0983)


   

Carboetomidate

ethyl 1-(1-phenylethyl)-1H-pyrrole-2-carboxylate

C15H17NO2 (243.1259)


   

N-((1R,2S,4S)-Bicyclo[2.2.1]heptan-2-yl)-9-methyl-9H-purin-6-amine

N-((1R,2S,4S)-Bicyclo[2.2.1]heptan-2-yl)-9-methyl-9H-purin-6-amine

C13H17N5 (243.1484)


   

Diethyl 4-aminobenzylphosphonate

diethyl [(4-aminophenyl)methyl]phosphonate

C11H18NO3P (243.1024)


   

Meluadrine

1-(2-Chloro-4-hydroxyphenyl)-tert-butylaminoethanol hydrochloride

C12H18ClNO2 (243.1026)


HOKU-81 (4-Hydroxytulobuterol) is one of the metabolites of Tulobuterol (HY-B1810). HOKU-81 is a potent and selective β2-adrenoceptor stimulant. HOKU-81 has bronchodilating effect[1][2].

   

4-Amino-5-hydroxy-1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-amino-5-hydroxy-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H13N3O5 (243.0855)


   

Taribavirin

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboximidamide

C8H13N5O4 (243.0967)


   

Atanine

4-methoxy-3-(3-methylbut-2-enyl)-1H-quinolin-2-one

C15H17NO2 (243.1259)


Atanine is a natural product found in Ravenia spectabilis, Zanthoxylum zanthoxyloides, and Zanthoxylum wutaiense with data available.

   

Vertilecanin A methyl ester

(-)-Vertilecanin A methyl ester

C14H13NO3 (243.0895)


   
   

9-ETHYL-8-METHOXYFURO[2,3-B]QUINOLIN-4-ONE

9-ETHYL-8-METHOXYFURO[2,3-B]QUINOLIN-4-ONE

C14H13NO3 (243.0895)


   

N-Methylhaplofoline

N-Methylkhaplofoline

C15H17NO2 (243.1259)


   

1-Azabicyclo[2.2.2]octan-3-one, 2-[(4-methoxyphenyl)methylene]-

1-Azabicyclo[2.2.2]octan-3-one, 2-[(4-methoxyphenyl)methylene]-

C15H17NO2 (243.1259)


   

MCULE-4201437053

MCULE-4201437053

C12H21NO4 (243.1471)


   

2(1H)-quinolinone, 4-hydroxy-1-methyl-3-(3-methyl-2-butenyl)-

2(1H)-quinolinone, 4-hydroxy-1-methyl-3-(3-methyl-2-butenyl)-

C15H17NO2 (243.1259)


   
   

Murrayacarine

Murrayacarine

C14H13NO3 (243.0895)


   

SCHEMBL8549994

SCHEMBL8549994

C14H13NO3 (243.0895)


   

Furo(2,3-b)quinolin-4(9H)-one, 9-ethyl-7-methoxy-

Furo(2,3-b)quinolin-4(9H)-one, 9-ethyl-7-methoxy-

C14H13NO3 (243.0895)


   
   
   

3-(2-methylbutyryloxy)tropan-6,7-diol

3-(2-methylbutyryloxy)tropan-6,7-diol

C12H21NO4 (243.1471)


   

Benz[a]anthracen-5-amine

Benz[a]anthracen-5-amine

C18H13N (243.1048)


   

SCHEMBL12672319

SCHEMBL12672319

C7H18NO6P (243.0872)


   
   

4-ETHOXY-8-METHOXYFURO[2,3-B]QUINOLINE

4-ETHOXY-8-METHOXYFURO[2,3-B]QUINOLINE

C14H13NO3 (243.0895)


   
   

5-Methoxy-2,2-dimethyl-4H-pyrano[2,3-b]chinolin

5-Methoxy-2,2-dimethyl-4H-pyrano[2,3-b]chinolin

C15H17NO2 (243.1259)


   

6-amino-3-pentofuranosylpyrimidin-4(3h)-one

6-amino-3-pentofuranosylpyrimidin-4(3h)-one

C9H13N3O5 (243.0855)


   
   

(E)-3-(5-acetoxy-3-methylpent-2-enamido)propanoic acid|pestalotiopamide E

(E)-3-(5-acetoxy-3-methylpent-2-enamido)propanoic acid|pestalotiopamide E

C11H17NO5 (243.1107)


   

caerulomycin J

caerulomycin J

C13H13N3O2 (243.1008)


A pyridine alkaloid that is 2,2-bipyridine substituted by a hydroxy group at position 4 and an (acetylamino)methyl group at position 6. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.

   
   

3-(1H-indol-3-ylmethyl)piperazine-2,5-dione

3-(1H-indol-3-ylmethyl)piperazine-2,5-dione

C13H13N3O2 (243.1008)


   

Clausenawalline D

Clausenawalline D

C14H13NO3 (243.0895)


   

sterostrein O

sterostrein O

C15H17NO2 (243.1259)


   

trikentramide A

trikentramide A

C15H17NO2 (243.1259)


   

Dictyobiphenyl A

Dictyobiphenyl A

C14H13NO3 (243.0895)


   

2-Amino-4,5-methylendioxy-2-hydroxymethyl-biphenyl|2-<2-Amino-phenyl>-4,5-methylendioxy-benzylalkohol|norismine|[6-(2-amino-phenyl)-benzo[1,3]dioxol-5-yl]-methanol

2-Amino-4,5-methylendioxy-2-hydroxymethyl-biphenyl|2-<2-Amino-phenyl>-4,5-methylendioxy-benzylalkohol|norismine|[6-(2-amino-phenyl)-benzo[1,3]dioxol-5-yl]-methanol

C14H13NO3 (243.0895)


   

Sceletenon|Sceletenone

Sceletenon|Sceletenone

C15H17NO2 (243.1259)


   
   
   
   

2,2,10-trimethyl-2,3,4,10-tetrahydro-5H-pyrano[2,3-b]quinolin-5-one

2,2,10-trimethyl-2,3,4,10-tetrahydro-5H-pyrano[2,3-b]quinolin-5-one

C15H17NO2 (243.1259)


   

2-{[1-(2-Amino-acetyl)-pyrrolidine-2-carbonyl]-amino}-propionic acid

2-{[1-(2-Amino-acetyl)-pyrrolidine-2-carbonyl]-amino}-propionic acid

C10H17N3O4 (243.1219)


   

SCHEMBL16620343

SCHEMBL16620343

C10H17N3O4 (243.1219)


   
   

salsolidine

6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride,99\\%

C12H18ClNO2 (243.1026)


   

Cytidine

Cytidine,cell culture tested

C9H13N3O5 (243.0855)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; UHDGCWIWMRVCDJ_STSL_0155_Cytidine_8000fmol_180506_S2_LC02_MS02_107; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.051 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3]. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3]. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3].

   

Agomelatine

N-[2-(7-methoxy-1-naphthalenyl)ethyl]-acetamide

C15H17NO2 (243.1259)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].

   

8-acetamido-2-methyl-7-oxononanoic acid

NCGC00380389-01!8-acetamido-2-methyl-7-oxononanoic acid

C12H21NO4 (243.1471)


   

cytarabine

cytarabine

C9H13N3O5 (243.0855)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites COVID info from COVID-19 Disease Map D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity. Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity.

   

8-acetamido-2-methyl-7-oxononanoic acid

8-acetamido-2-methyl-7-oxononanoic acid

C12H21NO4 (243.1471)


   

3-hydroxy-C8-homoserine lactone

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)octanamide

C12H21NO4 (243.1471)


CONFIDENCE standard compound; INTERNAL_ID 215

   

Cytidine; LC-tDDA; CE10

Cytidine; LC-tDDA; CE10

C9H13N3O5 (243.0855)


   

Cytidine; LC-tDDA; CE20

Cytidine; LC-tDDA; CE20

C9H13N3O5 (243.0855)


   

Cytidine; LC-tDDA; CE30

Cytidine; LC-tDDA; CE30

C9H13N3O5 (243.0855)


   

Cytidine; LC-tDDA; CE40

Cytidine; LC-tDDA; CE40

C9H13N3O5 (243.0855)


   

5-Hydroxy-deoxycytidine

5-Hydroxy-deoxycytidine

C9H13N3O5 (243.0855)


   
   
   
   
   
   
   
   

N-Desmethyltolmetin

N-Desmethyltolmetin

C14H13NO3 (243.0895)


   

1-((4-amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridinium

1-((4-amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridinium

C13H17N5 (243.1484)


   

2-ethylacrylylcarnitine

2-ethylacrylylcarnitine

C12H21NO4 (243.1471)


   

Frovatriptan

(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide

C14H17N3O (243.1372)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

GLN-Pro

4-carbamoyl-2-(pyrrolidin-2-ylformamido)butanoic acid

C10H17N3O4 (243.1219)


   

Pro-GLN

1-(2-amino-4-carbamoylbutanoyl)pyrrolidine-2-carboxylic acid

C10H17N3O4 (243.1219)


A dipeptide formed from L-proline and L-glutamine residues.

   

Pro-gglu

1-[2-amino-4-(C-hydroxycarbonimidoyl)butanoyl]pyrrolidine-2-carboxylic acid

C10H17N3O4 (243.1219)


   

GGlu-pro

4-(C-hydroxycarbonimidoyl)-2-(pyrrolidin-2-ylformamido)butanoic acid

C10H17N3O4 (243.1219)


   

CAR 5:1

3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


   

3O-C7-HTL

N-(3-oxo-heptanoyl)-homoserine thiolactone

C11H17NO3S (243.0929)


   

3OH-C8-HSL

N-(3-hydroxy-octanoyl)-homoserine lactone

C12H21NO4 (243.1471)


   

1-O-tert-butyl 3-O-methyl (3R)-piperidine-1,3-dicarboxylate

1-O-tert-butyl 3-O-methyl (3R)-piperidine-1,3-dicarboxylate

C12H21NO4 (243.1471)


   

Penthyl(5-fluro-2-oxo-1, 2-dihydropyriMidin-4-yl) carbaMate

Penthyl(5-fluro-2-oxo-1, 2-dihydropyriMidin-4-yl) carbaMate

C10H14FN3O3 (243.1019)


   

ethyl 4-(2-oxopyridin-1(2H)-yl)benzoate

ethyl 4-(2-oxopyridin-1(2H)-yl)benzoate

C14H13NO3 (243.0895)


   

5-(2-methoxy-5-methylphenyl)pyridine-3-carboxylic acid

5-(2-methoxy-5-methylphenyl)pyridine-3-carboxylic acid

C14H13NO3 (243.0895)


   

tert-butyl N-(4,4,4-trifluoro-3-hydroxybutyl)carbamate

tert-butyl N-(4,4,4-trifluoro-3-hydroxybutyl)carbamate

C9H16F3NO3 (243.1082)


   

Cyclo(-Gly-Trp)

Cyclo(glycyltryptophyl)

C13H13N3O2 (243.1008)


A natural product found in Talaromyces thermophilus.

   

(1-Furan-2-yl-but-3-enyl)-(4-methoxy-phenyl)-amine

(1-Furan-2-yl-but-3-enyl)-(4-methoxy-phenyl)-amine

C15H17NO2 (243.1259)


   

2s,3s-1-boc-2-methyl-piperidine-3-carboxylic acid

2s,3s-1-boc-2-methyl-piperidine-3-carboxylic acid

C12H21NO4 (243.1471)


   

D-Homophenylalanine ethyl ester hydrochloride

D-Homophenylalanine ethyl ester hydrochloride

C12H18ClNO2 (243.1026)


   

n-(4-fluorobenzoyl)-phenyl-ethylamine

n-(4-fluorobenzoyl)-phenyl-ethylamine

C15H14FNO (243.1059)


   

1-(tert-butoxycarbonyl)azepane-4-carboxylic acid

1-(tert-butoxycarbonyl)azepane-4-carboxylic acid

C12H21NO4 (243.1471)


   

1-(tert-butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid

1-(tert-butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid

C12H21NO4 (243.1471)


   

(1-Boc-Piperidine-3yl)aceticacid

(1-Boc-Piperidine-3yl)aceticacid

C12H21NO4 (243.1471)


   

2-METHYL-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE

2-METHYL-6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROCHLORIDE

C12H18ClNO2 (243.1026)


   

4-METHYL-5-[3-(3-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]-1,3-THIAZOL-2-AMINE

4-METHYL-5-[3-(3-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]-1,3-THIAZOL-2-AMINE

C14H13NO3 (243.0895)


   

1-tert-Butyl 2-methyl 2-methylpyrrolidine-1,2-dicarboxylate

1-tert-Butyl 2-methyl 2-methylpyrrolidine-1,2-dicarboxylate

C12H21NO4 (243.1471)


   

2s,3r-1-boc-2-methyl-piperidine-3-carboxylic acid

2s,3r-1-boc-2-methyl-piperidine-3-carboxylic acid

C12H21NO4 (243.1471)


   

5-Nitro-N-(1-phenylethyl)-2-pyridinamine

5-Nitro-N-(1-phenylethyl)-2-pyridinamine

C13H13N3O2 (243.1008)


   
   

6-(3-ethoxyphenyl)pyridine-3-carboxylic acid

6-(3-ethoxyphenyl)pyridine-3-carboxylic acid

C14H13NO3 (243.0895)


   

1-Acetyl-5-(2-aminopropyl)-7-indolinecarbonitrile

1-Acetyl-5-(2-aminopropyl)-7-indolinecarbonitrile

C14H17N3O (243.1372)


   

1-[(2-phenyltriazol-4-yl)methyl]piperazine

1-[(2-phenyltriazol-4-yl)methyl]piperazine

C13H17N5 (243.1484)


   

ethyl 6-phenoxynicotinate

ethyl 6-phenoxynicotinate

C14H13NO3 (243.0895)


   

6-Chrysenamine

6-Aminochrysene

C18H13N (243.1048)


D000970 - Antineoplastic Agents

   

Benzoylcholine Chloride

Benzoylcholine Chloride

C12H18ClNO2 (243.1026)


   

5-amino-2-(pyridin-3-ylmethylamino)benzoic acid

5-amino-2-(pyridin-3-ylmethylamino)benzoic acid

C13H13N3O2 (243.1008)


   

3-Butynoic acid, 2-[(methoxycarbonyl)amino]-4-(trimethylsilyl)-, methyl ester

3-Butynoic acid, 2-[(methoxycarbonyl)amino]-4-(trimethylsilyl)-, methyl ester

C10H17NO4Si (243.0927)


   

4-OXO-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

4-OXO-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER

C11H17NO5 (243.1107)


   

tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

C12H21NO4 (243.1471)


   

4-(3-methylbutoxy)pyridine-2-carboximidamide,hydrochloride

4-(3-methylbutoxy)pyridine-2-carboximidamide,hydrochloride

C11H18ClN3O (243.1138)


   

4-(Pentyloxy)picolinimidamide hydrochloride

4-(Pentyloxy)picolinimidamide hydrochloride

C11H18ClN3O (243.1138)


   

1-Benzyloxy-3-methyl-2-nitrobenzene

1-Benzyloxy-3-methyl-2-nitrobenzene

C14H13NO3 (243.0895)


   

2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopyrrolidin-2-yl]acetic acid

2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopyrrolidin-2-yl]acetic acid

C11H17NO5 (243.1107)


   

BENZOPHENONE-3,3,4,4-TETRACARBOXYLICACID

BENZOPHENONE-3,3,4,4-TETRACARBOXYLICACID

C14H13NO3 (243.0895)


   

1-Boc-2-Methylpipecolinic acid

1-Boc-2-Methylpipecolinic acid

C12H21NO4 (243.1471)


   

2-Naphthalenol,1-(4-morpholinylmethyl)-

2-Naphthalenol,1-(4-morpholinylmethyl)-

C15H17NO2 (243.1259)


   

3-(3-PHENOXYPHENYL)-DL-BETA-ALANINOL

3-(3-PHENOXYPHENYL)-DL-BETA-ALANINOL

C15H17NO2 (243.1259)


   

(1H-Indol-2-yl)(4-methylpiperazin-1-yl)methanone

(1H-Indol-2-yl)(4-methylpiperazin-1-yl)methanone

C14H17N3O (243.1372)


   

methyl 3-(5-methoxypyridin-3-yl)benzoate

methyl 3-(5-methoxypyridin-3-yl)benzoate

C14H13NO3 (243.0895)


   

3-BENZYLOXY-4-METHOXYBENZYLAMINE

3-BENZYLOXY-4-METHOXYBENZYLAMINE

C15H17NO2 (243.1259)


   

AMINO-(4-PHENOXY-PHENYL)-ACETIC ACID

AMINO-(4-PHENOXY-PHENYL)-ACETIC ACID

C14H13NO3 (243.0895)


   

1,2,3,5-Tetrahydro-spiro[4H-1-benzazepine-4,1-[2]cyclopentene]-3-carboxylic acid

1,2,3,5-Tetrahydro-spiro[4H-1-benzazepine-4,1-[2]cyclopentene]-3-carboxylic acid

C15H17NO2 (243.1259)


   

4-morpholin-4-ylquinazoline-6-carbaldehyde

4-morpholin-4-ylquinazoline-6-carbaldehyde

C13H13N3O2 (243.1008)


   

4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile

4-((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)benzonitrile

C14H18BNO2 (243.1431)


   

1-BENZYLPIPERIDIN-3-ONE HYDROCHLORIDE HYDRATE

1-BENZYLPIPERIDIN-3-ONE HYDROCHLORIDE HYDRATE

C12H18ClNO2 (243.1026)


   
   

(S)-di-tert-butyl aziridine-1,2-dicarboxylate

(S)-di-tert-butyl aziridine-1,2-dicarboxylate

C12H21NO4 (243.1471)


   

2-((4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)METHYL)BENZONITRILE

2-((4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)METHYL)BENZONITRILE

C14H18BNO2 (243.1431)


   
   

2-(tosylamino)butan-1-ol

2-(tosylamino)butan-1-ol

C11H17NO3S (243.0929)


   

3-(1,2,3,4-tetrahydrocarbazol-9-yl)propanoic acid

3-(1,2,3,4-tetrahydrocarbazol-9-yl)propanoic acid

C15H17NO2 (243.1259)


   

Indole-7-boronic acid pinacol ester

Indole-7-boronic acid pinacol ester

C14H18BNO2 (243.1431)


   

Indole-6-boronic acid pinacol ester

Indole-6-boronic acid pinacol ester

C14H18BNO2 (243.1431)


   

Urea,N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-

Urea,N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-

C9H14ClN5O (243.0887)


   

Cyclopentaneacetic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]- (9CI)

Cyclopentaneacetic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]- (9CI)

C12H21NO4 (243.1471)


   

(2S)-N-(Boc)-4-oxopipecolic acid

(2S)-N-(Boc)-4-oxopipecolic acid

C11H17NO5 (243.1107)


   

Boc-4-oxo-Pro-OMe

Boc-4-oxo-Pro-OMe

C11H17NO5 (243.1107)


   

N-Boc-4-oxo-L-proline methyl ester

N-Boc-4-oxo-L-proline methyl ester

C11H17NO5 (243.1107)


   

Indole-4-boronic acid pinacol ester

Indole-4-boronic acid pinacol ester

C14H18BNO2 (243.1431)


   

Methyl 5-cyclopropyl-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylate

Methyl 5-cyclopropyl-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylate

C13H13N3O2 (243.1008)


   

Methyl 2-amino-4-(p-tolyl)pyrimidine-5-carboxylate

Methyl 2-amino-4-(p-tolyl)pyrimidine-5-carboxylate

C13H13N3O2 (243.1008)


   

5-NITRO-8-(PYRROLIDIN-1-YL)QUINOLINE

5-NITRO-8-(PYRROLIDIN-1-YL)QUINOLINE

C13H13N3O2 (243.1008)


   

3-(Boc-amino)cyclohexanecarboxylic acid

3-(Boc-amino)cyclohexanecarboxylic acid

C12H21NO4 (243.1471)


   

1-(4-DIMETHYLAMINO-2-FLUORO-PHENYL)-3-(4-DIMETHYLIMMONIUM-2-FLUORO-CYCLOHEXA-2,5-DIEN-1-YLIDENE)-2-OXO-CYCLOBUTEN-4-OLATE

1-(4-DIMETHYLAMINO-2-FLUORO-PHENYL)-3-(4-DIMETHYLIMMONIUM-2-FLUORO-CYCLOHEXA-2,5-DIEN-1-YLIDENE)-2-OXO-CYCLOBUTEN-4-OLATE

C15H17NO2 (243.1259)


   

7-METHYL-8-(TRIFLUOROMETHYL)-3,4-DIHYDRO-1H-BENZO[B]AZEPIN-5(2H)-ONE

7-METHYL-8-(TRIFLUOROMETHYL)-3,4-DIHYDRO-1H-BENZO[B]AZEPIN-5(2H)-ONE

C12H12F3NO (243.0871)


   

4-[(2-Fluorophenyl)azo]-N,N-dimethylbenzenamine

4-[(2-Fluorophenyl)azo]-N,N-dimethylbenzenamine

C14H14FN3 (243.1172)


   

3-phenyl-9H-carbazole

3-phenyl-9H-carbazole

C18H13N (243.1048)


   

5-Indoleboronic acid pinacol ester

5-Indoleboronic acid pinacol ester

C14H18BNO2 (243.1431)


   

3-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-2-carboxylic acid

3-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-2-carboxylic acid

C12H21NO4 (243.1471)


   

4-[bis(prop-2-enyl)amino]-3-nitrobenzonitrile

4-[bis(prop-2-enyl)amino]-3-nitrobenzonitrile

C13H13N3O2 (243.1008)


   

ethyl 2,5-dimethyl-1-phenylpyrrole-3-carboxylate

ethyl 2,5-dimethyl-1-phenylpyrrole-3-carboxylate

C15H17NO2 (243.1259)


   

methyl 3-(3-aminophenoxy)benzoate

methyl 3-(3-aminophenoxy)benzoate

C14H13NO3 (243.0895)


   

2-anilino-4-methoxybenzoic acid

2-anilino-4-methoxybenzoic acid

C14H13NO3 (243.0895)


   

Methyl N-Boc-piperidine-3-carboxylate

Methyl N-Boc-piperidine-3-carboxylate

C12H21NO4 (243.1471)


   

3-Pyridazinecarboxylic acid, 6-[(phenylmethyl)amino]-, methyl ester

3-Pyridazinecarboxylic acid, 6-[(phenylmethyl)amino]-, methyl ester

C13H13N3O2 (243.1008)


   

3-(3-Formyl-2,5-dimethyl-pyrrol-1-yl)-benzoic acid

3-(3-Formyl-2,5-dimethyl-pyrrol-1-yl)-benzoic acid

C14H13NO3 (243.0895)


   

Benzoic acid,4-(3-formyl-2,5-dimethyl-1H-pyrrol-1-yl)-

Benzoic acid,4-(3-formyl-2,5-dimethyl-1H-pyrrol-1-yl)-

C14H13NO3 (243.0895)


   

1-Boc-4-methylpiperidine-4-carboxylic acid

1-Boc-4-methylpiperidine-4-carboxylic acid

C12H21NO4 (243.1471)


   

(1S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

(1S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

N-BOC-3-METHYL-4-PIPERIDINECARBOXYLIC ACID

N-BOC-3-METHYL-4-PIPERIDINECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

Sodium 3-(cyclohexylamino)-1-propanesulfonate

Sodium 3-(cyclohexylamino)-1-propanesulfonate

C9H18NNaO3S (243.0905)


   

(R)-4-(6-Hydroxynaphthalen-2-yl)-4-methyloxazolidin-2-one

(R)-4-(6-Hydroxynaphthalen-2-yl)-4-methyloxazolidin-2-one

C14H13NO3 (243.0895)


   

1,3-dimethyl-5-(4-nitrophenoxy)benzene

1,3-dimethyl-5-(4-nitrophenoxy)benzene

C14H13NO3 (243.0895)


   

4-Cyano-4-phenylcyclohexanone ethylene ketal

4-Cyano-4-phenylcyclohexanone ethylene ketal

C15H17NO2 (243.1259)


   

6-benzyloxy-2-nitrotoluene

6-benzyloxy-2-nitrotoluene

C14H13NO3 (243.0895)


   

2-phenyl-9H-carbazole

2-phenyl-9H-carbazole

C18H13N (243.1048)


   

Ethyl (R)-1-Boc-3-pyrrolidinecarboxylate

Ethyl (R)-1-Boc-3-pyrrolidinecarboxylate

C12H21NO4 (243.1471)


   

2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

C14H18BNO2 (243.1431)


   

(2-CHLOROPHENYL)PHENYL-METHANONE

(2-CHLOROPHENYL)PHENYL-METHANONE

C14H18BNO2 (243.1431)


   

1-Tert-Butoxycarbonylamino-Cyclohexanecarboxylic Acid

1-Tert-Butoxycarbonylamino-Cyclohexanecarboxylic Acid

C12H21NO4 (243.1471)


   

Benzoic acid, 3-[(6-amino-3-pyridazinyl)methyl]-, methyl ester

Benzoic acid, 3-[(6-amino-3-pyridazinyl)methyl]-, methyl ester

C13H13N3O2 (243.1008)


   

2-METHYL-5-CYANOPHENYL BORONIC ACID PINACOL ESTER

2-METHYL-5-CYANOPHENYL BORONIC ACID PINACOL ESTER

C14H18BNO2 (243.1431)


   

tetraethylammonium trifluoroacetate

tetraethylammonium trifluoroacetate

C10H20F3NO2 (243.1446)


   

4-(Cyanomethyl)benzeneboronic acid pinacol ester

4-(Cyanomethyl)benzeneboronic acid pinacol ester

C14H18BNO2 (243.1431)


   

trans-4-(Boc-Amino)cyclohexanecarboxylic acid

trans-4-(Boc-Amino)cyclohexanecarboxylic acid

C12H21NO4 (243.1471)


   

4-(9H-FLUOREN-9-YL)PYRIDINE

4-(9H-FLUOREN-9-YL)PYRIDINE

C18H13N (243.1048)


   

(R)-TERT-BUTYL 2,2-DIMETHYL-4-(2-OXOETHYL)OXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 2,2-DIMETHYL-4-(2-OXOETHYL)OXAZOLIDINE-3-CARBOXYLATE

C12H21NO4 (243.1471)


   

Alonimid

Alonimide

C14H13NO3 (243.0895)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

(3S,4R,5R,6S)-4-OXO-PENTANOICACID4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-P-TOLYLSULFAN

(3S,4R,5R,6S)-4-OXO-PENTANOICACID4,5-BIS-BENZYLOXY-6-BENZYLOXYMETHYL-2-P-TOLYLSULFAN

C11H13N7 (243.1232)


   

Azepane-1,3-dicarboxylic acid 1-tert-butyl ester

Azepane-1,3-dicarboxylic acid 1-tert-butyl ester

C12H21NO4 (243.1471)


   

1-(TERT-BUTOXYCARBONYL)-3-OXOPIPERIDINE-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-3-OXOPIPERIDINE-4-CARBOXYLIC ACID

C11H17NO5 (243.1107)


   

H-Ala-Pro-Gly-OH

H-Ala-Pro-Gly-OH

C10H17N3O4 (243.1219)


   

5-Benzyloxy-2-nitrotoluene

5-Benzyloxy-2-nitrotoluene

C14H13NO3 (243.0895)


   

4-(3-TRIFLUOROMETHYL-BENZYL)-PIPERIDINE

4-(3-TRIFLUOROMETHYL-BENZYL)-PIPERIDINE

C13H16F3N (243.1235)


   

6-ETHYL-2-METHYLQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

6-ETHYL-2-METHYLQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C15H17NO2 (243.1259)


   

L-Homophenylalanine ethyl ester hydrochloride

L-Homophenylalanine ethyl ester hydrochloride

C12H18ClNO2 (243.1026)


   

(S)-1-(tert-Butoxycarbonyl)-4,4-dimethylpyrrolidine-2-carboxylic acid

(S)-1-(tert-Butoxycarbonyl)-4,4-dimethylpyrrolidine-2-carboxylic acid

C12H21NO4 (243.1471)


   

CHEMBRDG-BB 9054791

CHEMBRDG-BB 9054791

C11H17NO5 (243.1107)


   

Boc-2-Amino-1-cyclohexanecarboxylic acid

Boc-2-Amino-1-cyclohexanecarboxylic acid

C12H21NO4 (243.1471)


   

4-(4-IMIDAZOL-1-YL-PHENOXY)-PIPERIDINE

4-(4-IMIDAZOL-1-YL-PHENOXY)-PIPERIDINE

C14H17N3O (243.1372)


   

[3-(Methoxymethoxy)phenyl](pyridin-2-yl)methanone

[3-(Methoxymethoxy)phenyl](pyridin-2-yl)methanone

C14H13NO3 (243.0895)


   

2-[(2-naphthalen-1-ylacetyl)amino]acetate

2-[(2-naphthalen-1-ylacetyl)amino]acetate

C14H13NO3 (243.0895)


   

(1r,2s)-2-(isopropylamino)-1,2-diphenylethanol

(1r,2s)-2-(isopropylamino)-1,2-diphenylethanol

C12H21NO4 (243.1471)


   

(1S,2S)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL

(1S,2S)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL

C12H21NO4 (243.1471)


   

boc-1,2-cis-achc-oh

boc-1,2-cis-achc-oh

C12H21NO4 (243.1471)


   

(1R,2R)-Boc-aminocyclohexane carboxylic acid

(1R,2R)-Boc-aminocyclohexane carboxylic acid

C12H21NO4 (243.1471)


   

tert-butyl 3-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

tert-butyl 3-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

C12H21NO4 (243.1471)


   

N-(tert-Butoxycarbonyl)-N-cyclopentylglycine

N-(tert-Butoxycarbonyl)-N-cyclopentylglycine

C12H21NO4 (243.1471)


   

(S)-2-CHLORO-1-(3,4-DICHLOROPHENYL)ETHANOL

(S)-2-CHLORO-1-(3,4-DICHLOROPHENYL)ETHANOL

C12H21NO4 (243.1471)


   

2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

C14H18BNO2 (243.1431)


   

(3R,4R)-1-[(tert-butoxy)carbonyl]-4-ethylpyrrolidine-3-carboxyli

(3R,4R)-1-[(tert-butoxy)carbonyl]-4-ethylpyrrolidine-3-carboxyli

C12H21NO4 (243.1471)


   

6-(3,4-Dimethoxyphenyl)-3-pyridinecarbaldehyde

6-(3,4-Dimethoxyphenyl)-3-pyridinecarbaldehyde

C14H13NO3 (243.0895)


   

N-Acetyl-3-acetoxy-5-phenylpyrrole

N-Acetyl-3-acetoxy-5-phenylpyrrole

C14H13NO3 (243.0895)


   

3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,2,4-oxadiazole-5-carboxylic acid

3-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,2,4-oxadiazole-5-carboxylic acid

C9H13N3O5 (243.0855)


   

3-(4-PROPOXY-PHENOXY)-PHENYLAMINE

3-(4-PROPOXY-PHENOXY)-PHENYLAMINE

C15H17NO2 (243.1259)


   

4-OXO-PIPERIDINE-1-CARBOXYLIC ACID 2-TRIMETHYLSILANYL-ETHYL ESTER

4-OXO-PIPERIDINE-1-CARBOXYLIC ACID 2-TRIMETHYLSILANYL-ETHYL ESTER

C11H21NO3Si (243.1291)


   

4-(4-METHOXYPHENOXY)PIPERIDINE HYDROCHLORIDE

4-(4-METHOXYPHENOXY)PIPERIDINE HYDROCHLORIDE

C12H18ClNO2 (243.1026)


   

Ethyl N-Boc-piperidine-4-carboxylate

Ethyl N-Boc-piperidine-4-carboxylate

C12H21NO4 (243.1471)


   

boc-dl-proline ethyl ester

boc-dl-proline ethyl ester

C12H21NO4 (243.1471)


   

ETHYL 3-(4-(AMINOMETHYL)PHENYL)PROPANOATE HYDROCHLORIDE

ETHYL 3-(4-(AMINOMETHYL)PHENYL)PROPANOATE HYDROCHLORIDE

C12H18ClNO2 (243.1026)


   

AMINO(3-PHENOXYPHENYL)ACETIC ACID

AMINO(3-PHENOXYPHENYL)ACETIC ACID

C14H13NO3 (243.0895)


   

(R)-1-BOC-2-PIPERIDINEACETIC ACID

(R)-1-BOC-2-PIPERIDINEACETIC ACID

C12H21NO4 (243.1471)


   

6-BENZYL-6,7-DIHYDRO-1H-PYRROLO[3,4-D]PYRIMIDINE-2,4(3H,5H)-DIONE

6-BENZYL-6,7-DIHYDRO-1H-PYRROLO[3,4-D]PYRIMIDINE-2,4(3H,5H)-DIONE

C13H13N3O2 (243.1008)


   

N,N-dimethyl-4-(phenylsulfanylmethyl)aniline

N,N-dimethyl-4-(phenylsulfanylmethyl)aniline

C15H17NS (243.1082)


   

(R)-2-(1-(tert-Butoxycarbonyl)piperidin-3-yl)acetic acid

(R)-2-(1-(tert-Butoxycarbonyl)piperidin-3-yl)acetic acid

C12H21NO4 (243.1471)


   

1-Benzyl-3-piperidone hydrochloride

1-Benzyl-3-piperidone hydrochloride

C12H18ClNO2 (243.1026)


   

Methyl 6-(3-methoxyphenyl)nicotinate

Methyl 6-(3-methoxyphenyl)nicotinate

C14H13NO3 (243.0895)


   

(S)-ETHYL 1-(2-METHOXY-2-OXOACETYL)PIPERIDINE-2-CARBOXYLATE

(S)-ETHYL 1-(2-METHOXY-2-OXOACETYL)PIPERIDINE-2-CARBOXYLATE

C11H17NO5 (243.1107)


   

1-(TERT-BUTOXYCARBONYL)-4-METHYLPIPERIDINE-3-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-METHYLPIPERIDINE-3-CARBOXYLIC ACID

C12H21NO4 (243.1471)


   

2-{[(tert-butoxy)carbonyl]amino}-3-cyclobutylpropanoic acid

2-{[(tert-butoxy)carbonyl]amino}-3-cyclobutylpropanoic acid

C12H21NO4 (243.1471)


   

3-Amino-4-(benzyloxy)benzoic acid

3-Amino-4-(benzyloxy)benzoic acid

C14H13NO3 (243.0895)


   

1-benzyl-3,3-difluoropiperidine-4,4-diol

1-benzyl-3,3-difluoropiperidine-4,4-diol

C12H15F2NO2 (243.1071)


   

2-AMINO-1-(4-BENZYLOXYPHENYL)ETHANOL

2-AMINO-1-(4-BENZYLOXYPHENYL)ETHANOL

C15H17NO2 (243.1259)


   

3-(1,1-dimethylethyl)-5-(ethoxycarboxy)-methylthio-1,2,4-triazole

3-(1,1-dimethylethyl)-5-(ethoxycarboxy)-methylthio-1,2,4-triazole

C10H17N3O2S (243.1041)


   

2-Amino-D-uridine

2-Amino-D-uridine

C9H13N3O5 (243.0855)


   

5-(BENZYLAMINOMETHYL)-2-METHOXYPHENOL

5-(BENZYLAMINOMETHYL)-2-METHOXYPHENOL

C15H17NO2 (243.1259)


   

Boc-Cis-1,4-ACHC-OH

Boc-Cis-1,4-ACHC-OH

C12H21NO4 (243.1471)


   

1,1-Bis(4-methoxyphenyl)methanamine

1,1-Bis(4-methoxyphenyl)methanamine

C15H17NO2 (243.1259)


   

meluadrine

meluadrine

C12H18ClNO2 (243.1026)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

4-Benzyloxy-2-nitrotoluene

4-Benzyloxy-2-nitrotoluene

C14H13NO3 (243.0895)


   

3-(dimethylamino)-1-(4-methoxyphenyl)propan-1-one hydrochloride

3-(dimethylamino)-1-(4-methoxyphenyl)propan-1-one hydrochloride

C12H18ClNO2 (243.1026)


   

2-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETONITRILE

2-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETONITRILE

C14H18BNO2 (243.1431)


   

tert-butyl N-[2-(2-amino-1,3-thiazol-4-yl)ethyl]carbamate

tert-butyl N-[2-(2-amino-1,3-thiazol-4-yl)ethyl]carbamate

C10H17N3O2S (243.1041)


   

3-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PROPANOIC ACID

3-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PROPANOIC ACID

C12H21NO4 (243.1471)


   

ETHYL 3-OXO-3-(QUINOLIN-2-YL)PROPANOATE

ETHYL 3-OXO-3-(QUINOLIN-2-YL)PROPANOATE

C14H13NO3 (243.0895)


   

3-AMINO-4-BUTYLAMINO-BENZENESULFONAMIDE

3-AMINO-4-BUTYLAMINO-BENZENESULFONAMIDE

C10H17N3O2S (243.1041)


   

2-amino-4-phenylmethoxybenzoic acid

2-amino-4-phenylmethoxybenzoic acid

C14H13NO3 (243.0895)


   

5-Benzyl-4-ethoxy-6-methyl-2-pyrimidinamine

5-Benzyl-4-ethoxy-6-methyl-2-pyrimidinamine

C14H17N3O (243.1372)


   

1-M-TOLYL-5-TRIFLUOROMETHYL-PYRROLIDIN-2-ONE

1-M-TOLYL-5-TRIFLUOROMETHYL-PYRROLIDIN-2-ONE

C12H12F3NO (243.0871)


   

1-[2-(trifluoromethyl)phenyl]piperidin-4-one

1-[2-(trifluoromethyl)phenyl]piperidin-4-one

C12H12F3NO (243.0871)


   

6-AMINO-2-METHOXY-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5-OL HYDROCHLORIDE

6-AMINO-2-METHOXY-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5-OL HYDROCHLORIDE

C12H18ClNO2 (243.1026)


   

4-(BENZYLAMINOMETHYL)-2-METHOXYPHENOL

4-(BENZYLAMINOMETHYL)-2-METHOXYPHENOL

C15H17NO2 (243.1259)


   

2-(2-naphthyl)indole

2-(2-naphthyl)indole

C18H13N (243.1048)


   

N-Phenylcarbazole

N-Phenylcarbazole

C18H13N (243.1048)


   

4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE

4-PHENYL-1-PIPERIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE

C14H17N3O (243.1372)


   

1H-INDOLE-2-BORONIC ACID PINACOL ESTER

1H-INDOLE-2-BORONIC ACID PINACOL ESTER

C14H18BNO2 (243.1431)


   

6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

C12H18ClNO2 (243.1026)


   

4-(4-Aminophenoxy)-N-methylpicolinamide

4-(4-Aminophenoxy)-N-methylpicolinamide

C13H13N3O2 (243.1008)


   

3-amino-4-(pyridin-3-ylmethylamino)benzoic acid

3-amino-4-(pyridin-3-ylmethylamino)benzoic acid

C13H13N3O2 (243.1008)


   

(3-cyclopropanecarbonyl-indol-1-yl)-acetic acid

(3-cyclopropanecarbonyl-indol-1-yl)-acetic acid

C14H13NO3 (243.0895)


   

2-amino-4-(3,4-dimethoxyphenyl)-1H-pyrrole-3-carbonitrile

2-amino-4-(3,4-dimethoxyphenyl)-1H-pyrrole-3-carbonitrile

C13H13N3O2 (243.1008)


   

2-tert-butyl-5-nitro-1H-indole-7-carbonitrile

2-tert-butyl-5-nitro-1H-indole-7-carbonitrile

C13H13N3O2 (243.1008)


   

5-Pyrimidinecarboxylicacid, 2-amino-4-phenyl-, ethyl ester

5-Pyrimidinecarboxylicacid, 2-amino-4-phenyl-, ethyl ester

C13H13N3O2 (243.1008)


   

tert-butyl 2-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

tert-butyl 2-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

C12H21NO4 (243.1471)


   

4-(BOC-AMINO)CYCLOHEXANECARBOXYLIC ACID

4-(BOC-AMINO)CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

1H-Indole,2-(1,1-dimethylethyl)-2,3-dihydro-5-(trifluoromethyl)-(9CI)

1H-Indole,2-(1,1-dimethylethyl)-2,3-dihydro-5-(trifluoromethyl)-(9CI)

C13H16F3N (243.1235)


   

S-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

S-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

C12H21NO4 (243.1471)


   

4H-Pyrido[1,2-a]pyrimidine-3-carboxaldehyde, 4-oxo-2-(1-pyrrolidinyl)-

4H-Pyrido[1,2-a]pyrimidine-3-carboxaldehyde, 4-oxo-2-(1-pyrrolidinyl)-

C13H13N3O2 (243.1008)


   

N-(6-AMINO-2-PYRIDINYL)-CARBAMICACIDPHENYLMETHYLESTER

N-(6-AMINO-2-PYRIDINYL)-CARBAMICACIDPHENYLMETHYLESTER

C13H13N3O2 (243.1008)


   

tert-butyl 4-(2-oxoethoxy)piperidine-1-carboxylate

tert-butyl 4-(2-oxoethoxy)piperidine-1-carboxylate

C12H21NO4 (243.1471)


   

4-(3-aminophenoxy)-N-methylpyridine-2-carboxamide

4-(3-aminophenoxy)-N-methylpyridine-2-carboxamide

C13H13N3O2 (243.1008)


   

(1S,3S)-N-BOC-1-AMINOCYCLOPENTANE-3-CARBOXYLIC ACID METHYL ESTER

(1S,3S)-N-BOC-1-AMINOCYCLOPENTANE-3-CARBOXYLIC ACID METHYL ESTER

C12H21NO4 (243.1471)


   

Gly-Pro-Ala

Gly-Pro-Ala-OH

C10H17N3O4 (243.1219)


   

1-HYDROXY-2-PHENYL-4,5,6,7-TETRAHYDRO-1H-BENZO[D]IMIDAZOL-4-ONE OXIME

1-HYDROXY-2-PHENYL-4,5,6,7-TETRAHYDRO-1H-BENZO[D]IMIDAZOL-4-ONE OXIME

C13H13N3O2 (243.1008)


   

3-Amino-1-(4-methyl-piperazin-1-yl)-1-propanone 2HCl

3-Amino-1-(4-methyl-piperazin-1-yl)-1-propanone 2HCl

C8H19Cl2N3O (243.0905)


   

Piperazine, 1-methyl-4-[(methylamino)acetyl]- (9CI)

Piperazine, 1-methyl-4-[(methylamino)acetyl]- (9CI)

C8H19Cl2N3O (243.0905)


   

(2S)-2-HYDROXY-3-METHYL-N-[(2S)-1-{[(1S)-3-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-1-YL]AMINO}-1-OXOPROPAN-2-YL]BUTANAMIDE

(2S)-2-HYDROXY-3-METHYL-N-[(2S)-1-{[(1S)-3-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-1-YL]AMINO}-1-OXOPROPAN-2-YL]BUTANAMIDE

C12H21NO4 (243.1471)


   

2-[(2-METHOXYPHENYL)AMINO]-BENZOIC ACID

2-[(2-METHOXYPHENYL)AMINO]-BENZOIC ACID

C14H13NO3 (243.0895)


   

2-((4-METHOXYPHENYL)AMINO)BENZOIC ACID

2-((4-METHOXYPHENYL)AMINO)BENZOIC ACID

C14H13NO3 (243.0895)


   

3-cyclobutyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

3-cyclobutyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

C12H21NO4 (243.1471)


   

5-Nitro-N-[(1R)-1-phenylethyl]-2-pyridinamine

5-Nitro-N-[(1R)-1-phenylethyl]-2-pyridinamine

C13H13N3O2 (243.1008)


   

3-(4-methoxyphenoxy)piperidine

3-(4-methoxyphenoxy)piperidine

C12H18ClNO2 (243.1026)


   

2-AMINO-5-BENZYL-4-METHYL-3-THIOPHENECARBOXAMIDE

2-AMINO-5-BENZYL-4-METHYL-3-THIOPHENECARBOXAMIDE

C12H18ClNO2 (243.1026)


   

cis-3-{[(tert-butoxy)carbonyl]amino}cyclohexane-1-carboxylic acid

cis-3-{[(tert-butoxy)carbonyl]amino}cyclohexane-1-carboxylic acid

C12H21NO4 (243.1471)


   

ethyl 4-(pyrimidin-2-ylamino)benzoate

ethyl 4-(pyrimidin-2-ylamino)benzoate

C13H13N3O2 (243.1008)


   

2-Chrysenamine

2-Chrysenamine

C18H13N (243.1048)


   

ethyl 2,5,7-trimethylquinoline-3-carboxylate

ethyl 2,5,7-trimethylquinoline-3-carboxylate

C15H17NO2 (243.1259)


   

2,5,8-TRIMETHYLQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

2,5,8-TRIMETHYLQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C15H17NO2 (243.1259)


   

ethyl 2,6,8-trimethylquinoline-3-carboxylate

ethyl 2,6,8-trimethylquinoline-3-carboxylate

C15H17NO2 (243.1259)


   

3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C14H18BNO2 (243.1431)


   

3,4-dimethoxyphenyl 2-pyridyl ketone

3,4-dimethoxyphenyl 2-pyridyl ketone

C14H13NO3 (243.0895)


   

(S)-2-BENZYL-2-N-BOCAMINO-ETHYLTHIOL

(S)-2-BENZYL-2-N-BOCAMINO-ETHYLTHIOL

C12H21NO4 (243.1471)


   

tert-butyl 6-cyanopyrrolo[2,3-b]pyridine-1-carboxylate

tert-butyl 6-cyanopyrrolo[2,3-b]pyridine-1-carboxylate

C13H13N3O2 (243.1008)


   

4,4-dimethoxy-n-methyldiphenylamine

4,4-dimethoxy-n-methyldiphenylamine

C15H17NO2 (243.1259)


   

methyl (E)-3-phenyl-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

methyl (E)-3-phenyl-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate

C13H13N3O2 (243.1008)


   

N-(4-Hydroxyphenyl)-2-methoxybenzamide

N-(4-Hydroxyphenyl)-2-methoxybenzamide

C14H13NO3 (243.0895)


   

3-Acetyl-4-hydroxy-6-methyl-1-phenyl-2-pyridone

3-Acetyl-4-hydroxy-6-methyl-1-phenyl-2-pyridone

C14H13NO3 (243.0895)


   

2-(BIS-(2-PYRIDYLMETHYL)-AMINO)-ETHANOL

2-(BIS-(2-PYRIDYLMETHYL)-AMINO)-ETHANOL

C14H17N3O (243.1372)


   

tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate

tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate

C12H21NO4 (243.1471)


   

3-Amino-4-(diethylamino)benzenesulfonamide

3-Amino-4-(diethylamino)benzenesulfonamide

C10H17N3O2S (243.1041)


   

Boc-L-Cyclopentylglycine

Boc-L-Cyclopentylglycine

C12H21NO4 (243.1471)


   

Ethyl 1-Boc-3-Pyrrolidinecarboxylate

Ethyl 1-Boc-3-Pyrrolidinecarboxylate

C12H21NO4 (243.1471)


   

(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride

(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride

C12H18ClNO2 (243.1026)


   

Quinoline, 6-(triethylsilyl)- (9CI)

Quinoline, 6-(triethylsilyl)- (9CI)

C15H21NSi (243.1443)


   
   

2-OXO-3-QUINOLIN-2-YL-PROPIONIC ACID ETHYL ESTER

2-OXO-3-QUINOLIN-2-YL-PROPIONIC ACID ETHYL ESTER

C14H13NO3 (243.0895)


   

N-Boc-1,4-Dioxa-8-aza-spiro[4.5]decane

N-Boc-1,4-Dioxa-8-aza-spiro[4.5]decane

C12H21NO4 (243.1471)


   
   

Ethyl 1-[ethoxy(oxo)acetyl]-L-prolinate

Ethyl 1-[ethoxy(oxo)acetyl]-L-prolinate

C11H17NO5 (243.1107)


   

R-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

R-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

C12H21NO4 (243.1471)


   
   

5,6-dimethoxy-2-aminotetraline hydrochloride

5,6-dimethoxy-2-aminotetraline hydrochloride

C12H18ClNO2 (243.1026)


   

(S)-tert-Butyl 2,2-dimethyl-4-(2-oxoethyl)oxazolidine-3-carboxylate

(S)-tert-Butyl 2,2-dimethyl-4-(2-oxoethyl)oxazolidine-3-carboxylate

C12H21NO4 (243.1471)


   

1-(4-TRIFLUOROMETHYL-PHENYL)-PIPERIDIN-2-ONE

1-(4-TRIFLUOROMETHYL-PHENYL)-PIPERIDIN-2-ONE

C12H12F3NO (243.0871)


   

1-(3-TRIFLUOROBENZENE)PIPERAZINEHYDROBROMIDE

1-(3-TRIFLUOROBENZENE)PIPERAZINEHYDROBROMIDE

C12H12F3NO (243.0871)


   

N-Boc-Piperidine-4-carboxylic acid methyl ester

N-Boc-Piperidine-4-carboxylic acid methyl ester

C12H21NO4 (243.1471)


   

7-methoxy-4-piperazin-1-ylquinoline

7-methoxy-4-piperazin-1-ylquinoline

C14H17N3O (243.1372)


   

Isoquinoline,1,2,3,4-tetrahydro-6,7-dimethoxy-3-methyl-, hydrochloride (1:1)

Isoquinoline,1,2,3,4-tetrahydro-6,7-dimethoxy-3-methyl-, hydrochloride (1:1)

C12H18ClNO2 (243.1026)


   

N-(1-(2-HYDROXY-NAPHTHALEN-1-YL)-PROPYL)-ACETAMIDE

N-(1-(2-HYDROXY-NAPHTHALEN-1-YL)-PROPYL)-ACETAMIDE

C15H17NO2 (243.1259)


   

1-Boc-4-piperidylacetic acid

1-Boc-4-piperidylacetic acid

C12H21NO4 (243.1471)


   

Tert-butyl 5-(2-aminoethyl)thiazol-2-ylcarbamate

Tert-butyl 5-(2-aminoethyl)thiazol-2-ylcarbamate

C10H17N3O2S (243.1041)


   

methyl 1-boc-piperidine-2-carboxylate

methyl 1-boc-piperidine-2-carboxylate

C12H21NO4 (243.1471)


   

4-acetoxy-1-(acetylamino)naphthalene

4-acetoxy-1-(acetylamino)naphthalene

C14H13NO3 (243.0895)


   

5-[4-(Trifluoromethyl)phenyl]-2-piperidinone

5-[4-(Trifluoromethyl)phenyl]-2-piperidinone

C12H12F3NO (243.0871)


   

1-Boc-2-Methylpiperidine-4-carboxylic Acid

1-Boc-2-Methylpiperidine-4-carboxylic Acid

C12H21NO4 (243.1471)


   

Arabinan

cytarabine

C9H13N3O5 (243.0855)


Arabinans devoid of other sugars have been isolated from mustard seeds. Heteroarabinans have been found in sugar beet and apples.

   

(3,4-DIMETHOXY-BENZYL)-PHENYL-AMINE

(3,4-DIMETHOXY-BENZYL)-PHENYL-AMINE

C15H17NO2 (243.1259)


   

1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-4-methoxy-1,3,5-triazin-2(1H)-one

1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-4-methoxy-1,3,5-triazin-2(1H)-one

C9H13N3O5 (243.0855)


   

(2S,4R)-4-amino-2-methyl-5-phenylpentanoic acid hydrochloride

(2S,4R)-4-amino-2-methyl-5-phenylpentanoic acid hydrochloride

C12H18ClNO2 (243.1026)


   
   

6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-amine hydrochloride

6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-amine hydrochloride

C11H18ClN3O (243.1138)


   

METHYL (2S)-2-AMINO-3-(2,4-DIMETHYLPHENYL)PROPANOATE HYDROCHLORIDE

METHYL (2S)-2-AMINO-3-(2,4-DIMETHYLPHENYL)PROPANOATE HYDROCHLORIDE

C12H18ClNO2 (243.1026)


   

3-Cyclohexyl-1H-indole-6-carboxylic acid

3-Cyclohexyl-1H-indole-6-carboxylic acid

C15H17NO2 (243.1259)


   

5-NITRO-6-(PYRROLIDIN-1-YL)QUINOLINE

5-NITRO-6-(PYRROLIDIN-1-YL)QUINOLINE

C13H13N3O2 (243.1008)


   

1-(2-HYDROXYMETHYLPHENYL)PIPERIDIN-4-OL HYDROCHLORIDE

1-(2-HYDROXYMETHYLPHENYL)PIPERIDIN-4-OL HYDROCHLORIDE

C12H18ClNO2 (243.1026)


   
   

Boc-5,5-dimethyl-DL-Pro-OH

Boc-5,5-dimethyl-DL-Pro-OH

C12H21NO4 (243.1471)


   

ethyl 4-amino-2-phenylpyrimidine-5-carboxylate

ethyl 4-amino-2-phenylpyrimidine-5-carboxylate

C13H13N3O2 (243.1008)


   

4-(diethylaminomethyl)benzoic acid,hydrochloride

4-(diethylaminomethyl)benzoic acid,hydrochloride

C12H18ClNO2 (243.1026)


   

2-((4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO)BENZOIC ACID

2-((4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO)BENZOIC ACID

C13H13N3O2 (243.1008)


   

N~1~-benzyl-4-nitro-1,2-benzenediamine

N~1~-benzyl-4-nitro-1,2-benzenediamine

C13H13N3O2 (243.1008)


   

1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde

1-(1,3-benzodioxol-5-yl)-2,5-dimethylpyrrole-3-carbaldehyde

C14H13NO3 (243.0895)


   

2-(4-Oxocyclohexyl)-1H-isoindole-1,3(2H)-dione

2-(4-Oxocyclohexyl)-1H-isoindole-1,3(2H)-dione

C14H13NO3 (243.0895)


   

(3R)-3-AMINOMETHYL-1-BENZYLPYRROLIDINE

(3R)-3-AMINOMETHYL-1-BENZYLPYRROLIDINE

C11H13N7 (243.1232)


   

N-METHYL-1-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)METHANAMINE

N-METHYL-1-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)METHANAMINE

C10H17N3O4 (243.1219)


   

TRANS-2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

TRANS-2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

(1R,3S)-3-BOC-AMINO-CYCLOHEXANECARBOXYLIC ACID

(1R,3S)-3-BOC-AMINO-CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

(S)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

(S)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

C12H21NO4 (243.1471)


   

(R)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

(R)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

C12H21NO4 (243.1471)


   

3,4-diamino-N,N-diethylbenzenesulfonamide

3,4-diamino-N,N-diethylbenzenesulfonamide

C10H17N3O2S (243.1041)


   

6-(2,5-DIMETHYLPHENOXY)NICOTINIC ACID

6-(2,5-DIMETHYLPHENOXY)NICOTINIC ACID

C14H13NO3 (243.0895)


   

1-(2,5-Dimethoxy-4-i-propylthiophenyl)-2-aminopropane

1-(2,5-Dimethoxy-4-i-propylthiophenyl)-2-aminopropane

C12H21NO2S (243.1293)


   

8-BENZYL-1,3,8-TRIAZA-SPIRO[4.5]DEC-1-EN-4-ONE

8-BENZYL-1,3,8-TRIAZA-SPIRO[4.5]DEC-1-EN-4-ONE

C14H17N3O (243.1372)


   

Acetamide, 2-(p-phenoxyphenoxy)-

Acetamide, 2-(p-phenoxyphenoxy)-

C14H13NO3 (243.0895)


   

2-(morpholin-4-ylmethyl)quinolin-6-amine

2-(morpholin-4-ylmethyl)quinolin-6-amine

C14H17N3O (243.1372)


   

2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-methyl-1H-indole

2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-methyl-1H-indole

C14H18BNO2 (243.1431)


   

6-piperidin-4-yloxyisoquinolin-3-amine

6-piperidin-4-yloxyisoquinolin-3-amine

C14H17N3O (243.1372)


   

3-(Diphenylphosphino)-1-propylamine

3-(Diphenylphosphino)-1-propylamine

C15H18NP (243.1177)


   

Boc-L-Pyroglutamic acid methyl ester

Boc-L-Pyroglutamic acid methyl ester

C11H17NO5 (243.1107)


   

2-amino-5-(4-aminophenoxy)benzamide

2-amino-5-(4-aminophenoxy)benzamide

C13H13N3O2 (243.1008)


   

(1-OXOPROPOXY)-,S-(FLUOROMETHYL)ESTER,(6A,11A,16A,17A)-

(1-OXOPROPOXY)-,S-(FLUOROMETHYL)ESTER,(6A,11A,16A,17A)-

C15H17NS (243.1082)


   

6-METHOXY-7,8,9,10-TETRAHYDRO-6H-[1,2,5]OXADIAZOLO[3,4-C]CARBAZOLE

6-METHOXY-7,8,9,10-TETRAHYDRO-6H-[1,2,5]OXADIAZOLO[3,4-C]CARBAZOLE

C13H13N3O2 (243.1008)


   

2-(2-Oxocyclohexyl)-1H-isoindole-1,3(2H)-dione

2-(2-Oxocyclohexyl)-1H-isoindole-1,3(2H)-dione

C14H13NO3 (243.0895)


   

Ammonium citrate

Ammonium citrate tribasic

C6H17N3O7 (243.1066)


Emulsifier and acidity regulator used in the food industry Citric acid triammonium (Triammonium citrate) is formed by Citric acid (HY-N1428) reacting with ammonia in a molar ratio of 1:3. Citric acid triammonium can be used as the carbon source to prepare carbon quantum dots (CDs). Citric acid triammonium with higher nitrogen components might promote the nitrogen-based functional groups in CDs, leading to a more efficient emission-color tunability[1][2].

   

Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate

Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate

C12H21NO4 (243.1471)


   

Methyl 4-(4-aminophenoxy)benzoate

Methyl 4-(4-aminophenoxy)benzoate

C14H13NO3 (243.0895)


   

(R)-1-tert-Butyl 2-methyl 5-oxopyrrolidine-1,2-dicarboxylate

(R)-1-tert-Butyl 2-methyl 5-oxopyrrolidine-1,2-dicarboxylate

C11H17NO5 (243.1107)


   

N-Boc-2-Piperidineacetic Acid

N-Boc-2-Piperidineacetic Acid

C12H21NO4 (243.1471)


   

5-(2,6-Dimethoxyphenyl)-3-pyridinecarbaldehyde

5-(2,6-Dimethoxyphenyl)-3-pyridinecarbaldehyde

C14H13NO3 (243.0895)


   

Ethyl 3-Oxo-3-(6-quinolyl)propanoate

Ethyl 3-Oxo-3-(6-quinolyl)propanoate

C14H13NO3 (243.0895)


   

3-Methyl-5-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzonitrile

3-Methyl-5-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzonitrile

C14H18BNO2 (243.1431)


   

Taribavirin

Taribavirin

C8H13N5O4 (243.0967)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Tepilamide fumarate

Tepilamide fumarate

C11H17NO5 (243.1107)


C308 - Immunotherapeutic Agent

   

5-Amino-5-deoxyuridine

5-Amino-5-deoxyuridine

C9H13N3O5 (243.0855)


   

1,3,5-Triazine-2,4-diamine, N-ethyl-N-(1-methylethyl)-6-(methylsulfinyl)-

1,3,5-Triazine-2,4-diamine, N-ethyl-N-(1-methylethyl)-6-(methylsulfinyl)-

C9H17N5OS (243.1154)


   

Urea, N-(2-methoxy-4-pyridinyl)-N-phenyl-

Urea, N-(2-methoxy-4-pyridinyl)-N-phenyl-

C13H13N3O2 (243.1008)


   

Ethanamine, N,N-diethyl-2-(4-methylphenoxy)-, hydrochloride

Ethanamine, N,N-diethyl-2-(4-methylphenoxy)-, hydrochloride

C13H22ClNO (243.139)


   
   

N-0861 racemate

N-0861 racemate

C13H17N5 (243.1484)


   

N-Methyl-2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-5-amine

N-Methyl-2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-5-amine

C11H12F3N3 (243.0983)


   

6-Azathymidine

6-Azathymidine

C9H13N3O5 (243.0855)


A N-glycosyl-1,2,4-triazine that is the 6-aza analogue of thymidine.

   

L-alanylglycyl-L-proline

L-alanylglycyl-L-proline

C10H17N3O4 (243.1219)


   

Prolyl-Glutamine

Prolyl-Glutamine

C10H17N3O4 (243.1219)


   

3-nitro-N-(2-phenylethyl)-2-Pyridinamine

3-nitro-N-(2-phenylethyl)-2-Pyridinamine

C13H13N3O2 (243.1008)


   

(2E)-2-[(4-methoxyphenyl)methylidene]-1-azabicyclo[2.2.2]octan-3-one

(2E)-2-[(4-methoxyphenyl)methylidene]-1-azabicyclo[2.2.2]octan-3-one

C15H17NO2 (243.1259)


   

N-(2-fluorophenyl)-3-phenylpropanamide

N-(2-fluorophenyl)-3-phenylpropanamide

C15H14FNO (243.1059)


   

Methanone, (3-amino-4,5-dihydroxyphenyl)(4-methylphenyl)-

Methanone, (3-amino-4,5-dihydroxyphenyl)(4-methylphenyl)-

C14H13NO3 (243.0895)


   

N-(3-imidazol-1-ylpropyl)-7H-purin-6-amine

N-(3-imidazol-1-ylpropyl)-7H-purin-6-amine

C11H13N7 (243.1232)


   

6-Methyl-3-[(3-methylanilino)methylidene]pyran-2,4-dione

6-Methyl-3-[(3-methylanilino)methylidene]pyran-2,4-dione

C14H13NO3 (243.0895)


   

N-(Aminothioxomethyl)-5-oxo-1-propyl-2-pyrrolidineacetamide

N-(Aminothioxomethyl)-5-oxo-1-propyl-2-pyrrolidineacetamide

C10H17N3O2S (243.1041)


   

Styryloxazolone

Styryloxazolone

C14H13NO3 (243.0895)


   

L-Prolyl-L-alanylglycine

L-Prolyl-L-alanylglycine

C10H17N3O4 (243.1219)


   

3-Tert-butylmercapto-4-phenylpyridine

3-Tert-butylmercapto-4-phenylpyridine

C15H17NS (243.1082)


   

2-Tert-butylmercapto-4-phenylpyridine

2-Tert-butylmercapto-4-phenylpyridine

C15H17NS (243.1082)


   

2,3-Dihydroxypropyl 2-(dimethylamino)ethyl hydrogen phosphate

2,3-Dihydroxypropyl 2-(dimethylamino)ethyl hydrogen phosphate

C7H18NO6P (243.0872)


   

3-Methylbut-2-enoylcarnitine

3-[(3-methylbut-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


3-methylbut-2-enoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylbut-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-methylbut-2-enoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3-methylbut-2-enoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-amino-5-[(1R)-1-(1H-indol-3-yl)ethyl]-1,3-oxazol-4-ol

2-amino-5-[(1R)-1-(1H-indol-3-yl)ethyl]-1,3-oxazol-4-ol

C13H13N3O2 (243.1008)


   

1-(beta-D-xylopyranosyl)cytosine

1-(beta-D-xylopyranosyl)cytosine

C9H13N3O5 (243.0855)


An N-glycosyl compound that is cytosine in which the proton at position 1 is replaced by a beta-D-xylosyl residue.

   

2-[(8,9-dihydro-7H-purin-6-ylamino)methyl]phenol

2-[(8,9-dihydro-7H-purin-6-ylamino)methyl]phenol

C12H13N5O (243.112)


   

4-[(8,9-dihydro-7H-purin-6-ylamino)methyl]phenol

4-[(8,9-dihydro-7H-purin-6-ylamino)methyl]phenol

C12H13N5O (243.112)


   

gamma-L-glutamyl-L-orornithine-delta-lactam

gamma-L-glutamyl-L-orornithine-delta-lactam

C10H17N3O4 (243.1219)


   

3-[(8,9-dihydro-7H-purin-6-ylamino)methyl]phenol

3-[(8,9-dihydro-7H-purin-6-ylamino)methyl]phenol

C12H13N5O (243.112)


   

(2S)-2-amino-5-oxo-5-[[(3S)-2-oxopiperidin-3-yl]amino]pentanoic acid

(2S)-2-amino-5-oxo-5-[[(3S)-2-oxopiperidin-3-yl]amino]pentanoic acid

C10H17N3O4 (243.1219)


   

2-Tiglylcarnitine

2-Tiglylcarnitine

C12H21NO4 (243.1471)


   

(3E)-Tiglylcarnitine

(3E)-Tiglylcarnitine

C12H21NO4 (243.1471)


   

Tritylium

Tritylium

C19H15+ (243.1174)


   

S-methyl-L-ergothioneine

S-methyl-L-ergothioneine

C10H17N3O2S (243.1041)


An amino acid betaine that is ergothioneine in which the hydrogen attached to the sulfur is replaced by a methyl group. It has been isolated from the deepwater (500-1,600 m) marine sponge Macandrewia azorica.

   

2-methyl-N-(2,4,6-trimethylphenyl)-3-furancarboxamide

2-methyl-N-(2,4,6-trimethylphenyl)-3-furancarboxamide

C15H17NO2 (243.1259)


   

2-methyl-N-[(E)-1-pyridin-3-ylethylideneamino]furan-3-carboxamide

2-methyl-N-[(E)-1-pyridin-3-ylethylideneamino]furan-3-carboxamide

C13H13N3O2 (243.1008)


   

2-Cyano-N,N-diethyl-2-(phenyl-hydrazono)-acetamidine

2-Cyano-N,N-diethyl-2-(phenyl-hydrazono)-acetamidine

C13H17N5 (243.1484)


   

(2S)-2-[[2-[[(2S)-pyrrolidine-2-carbonyl]amino]acetyl]amino]propanoic Acid

(2S)-2-[[2-[[(2S)-pyrrolidine-2-carbonyl]amino]acetyl]amino]propanoic Acid

C10H17N3O4 (243.1219)


   

Alanylprolylglycine zwitterion

Alanylprolylglycine zwitterion

C10H17N3O4 (243.1219)


   

2-Hydroxy-3-methoxybenzaldehyde 2-pyridylhydrazone

2-Hydroxy-3-methoxybenzaldehyde 2-pyridylhydrazone

C13H13N3O2 (243.1008)


   
   

4-(ethoxymethylidene)-2-[(E)-2-phenylethenyl]-1,3-oxazol-5-one

4-(ethoxymethylidene)-2-[(E)-2-phenylethenyl]-1,3-oxazol-5-one

C14H13NO3 (243.0895)


   

N-(2-Pyrrolidinylcarbonyl)glutamine

N-(2-Pyrrolidinylcarbonyl)glutamine

C10H17N3O4 (243.1219)


   

Benzyl 3-ethyl-4-methyl-1H-pyrrole-2-carboxylate

Benzyl 3-ethyl-4-methyl-1H-pyrrole-2-carboxylate

C15H17NO2 (243.1259)


   

1-Propionylproline, TMS derivative

1-Propionylproline, TMS derivative

C11H21NO3Si (243.1291)


   

1,2,3,4-Tetrahydrocarbazole, TMS derivative

1,2,3,4-Tetrahydrocarbazole, TMS derivative

C15H21NSi (243.1443)


   

2-Aminoethyl (3-ethoxy-2-hydroxypropyl) hydrogen phosphate

2-Aminoethyl (3-ethoxy-2-hydroxypropyl) hydrogen phosphate

C7H18NO6P (243.0872)


   

(E)-3-(2-Oxopropylene)-1-para-tolyl-2,5-pyrrolidinedione

(E)-3-(2-Oxopropylene)-1-para-tolyl-2,5-pyrrolidinedione

C14H13NO3 (243.0895)


   
   

Biotinamide

Biotin amide

C10H17N3O2S (243.1041)


A monocarboxylic acid amide derived from biotin.

   

N-demethylindolmycin

(5S)-2-amino-5-[(1R)-1-(1H-indol-3-yl)ethyl]-1,3-oxazol-4(5H)-one

C13H13N3O2 (243.1008)


A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted at the 2 and 5-pro-S positions by amino and [(1R)-1-(1H-indol-3-yl)ethyl] groups, respectively.

   

gamma-Glutamyl-beta-cyanoalanine

gamma-Glutamyl-beta-cyanoalanine

C9H13N3O5 (243.0855)


A dipeptide composed of 3-cyano-L-alanine and L-glutamine joined by a peptide linkage formed from the side-chain of glutamine.

   

3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide

3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide

C12H21NO4 (243.1471)


   

O-Tiglyl-L-carnitine

O-Tiglyl-L-carnitine

C12H21NO4 (243.1471)


An O-acyl-L-carnitine compound having trans-2-methyl-2-butenoyl (tiglyl) as the acyl substituent.

   

Glutaminylproline

Glutaminylproline

C10H17N3O4 (243.1219)


   

2-ethylacryloylcarnitine

2-ethylacryloylcarnitine

C12H21NO4 (243.1471)


An O-acylcarnitine compound having 2-ethylacryloyl as the acyl substituent.

   

Prolyl-Gamma-glutamate

Prolyl-Gamma-glutamate

C10H17N3O4 (243.1219)


   

Triammonium citrate

Ammonium citrate tribasic

C6H17N3O7 (243.1066)


Citric acid triammonium (Triammonium citrate) is formed by Citric acid (HY-N1428) reacting with ammonia in a molar ratio of 1:3. Citric acid triammonium can be used as the carbon source to prepare carbon quantum dots (CDs). Citric acid triammonium with higher nitrogen components might promote the nitrogen-based functional groups in CDs, leading to a more efficient emission-color tunability[1][2].

   

Tiglylcarnitine

Tiglylcarnitine

C12H21NO4 (243.1471)


   

Ala-Gly-Pro

Ala-Gly-Pro

C10H17N3O4 (243.1219)


A tripeptide composed of L-alanine, glycine, and L-proline joined in sequence by peptide linkages.

   

O-Tiglylcarnitine

O-Tiglylcarnitine

C12H21NO4 (243.1471)


An O-acylcarnitine compound having trans-2-methyl-2-butenoyl (tiglyl) as the acyl substituent.

   
   

CAR 4:1(2Z);3Me

CAR 4:1(2Z);3Me

C12H21NO4 (243.1471)


   

Cyclo(Arg-Ser)

Cyclo(Arg-Ser)

C9H17N5O3 (243.1331)


   

Cyclo(Asn-Glu)

Cyclo(Asn-Glu)

C9H13N3O5 (243.0855)


   

Cyclo(Asp-Gln)

Cyclo(Asp-Gln)

C9H13N3O5 (243.0855)


   
   
   
   
   
   

YM348

YM348

C14H17N3O (243.1372)


YM348 is a potent and orally active 5-HT2C receptor agonist, which shows a high affinity for cloned human 5-HT2C receptor (Ki: 0.89 nM).

   

α-Cytidine

α-Cytidine

C9H13N3O5 (243.0855)


α-Cytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

(3s)-3-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3s)-3-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C13H13N3O2 (243.1008)


   

2-[(2s)-7-methyl-2h,3h-furo[3,2-h]isoquinolin-2-yl]propan-2-ol

2-[(2s)-7-methyl-2h,3h-furo[3,2-h]isoquinolin-2-yl]propan-2-ol

C15H17NO2 (243.1259)


   

(2r)-2,3,3,9-tetramethyl-2h-furo[2,3-b]quinolin-4-one

(2r)-2,3,3,9-tetramethyl-2h-furo[2,3-b]quinolin-4-one

C15H17NO2 (243.1259)


   

3-hydroxy-n-(2-oxooxolan-3-yl)octanimidic acid

3-hydroxy-n-(2-oxooxolan-3-yl)octanimidic acid

C12H21NO4 (243.1471)


   

(3s)-2,2,3,9-tetramethyl-3h-furo[2,3-b]quinolin-4-one

(3s)-2,2,3,9-tetramethyl-3h-furo[2,3-b]quinolin-4-one

C15H17NO2 (243.1259)


   

2-{7-methyl-2h,3h-furo[3,2-h]isoquinolin-2-yl}propan-2-ol

2-{7-methyl-2h,3h-furo[3,2-h]isoquinolin-2-yl}propan-2-ol

C15H17NO2 (243.1259)


   

14-imino-6-oxa-2,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),9,12(16)-trien-13-one

14-imino-6-oxa-2,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),9,12(16)-trien-13-one

C13H13N3O2 (243.1008)


   

3-Phenyl-4-azafluorene

2-Phenyl-5H-indeno[1,2-b]pyridine; 2-phenyl-5H-indeno[3,2-b]pyridine

C18H13N (243.1048)


{"Ingredient_id": "HBIN009460","Ingredient_name": "3-Phenyl-4-azafluorene","Alias": "2-Phenyl-5H-indeno[1,2-b]pyridine; 2-phenyl-5H-indeno[3,2-b]pyridine","Ingredient_formula": "C18H13N","Ingredient_Smile": "C1C2=C(C3=CC=CC=C31)N=C(C=C2)C4=CC=CC=C4","Ingredient_weight": "243.3 g/mol","OB_score": "32.9025835","CAS_id": "NA","SymMap_id": "SMIT04204","TCMID_id": "NA","TCMSP_id": "MOL001851","TCM_ID_id": "NA","PubChem_id": "618317","DrugBank_id": "NA"}

   

4,8-dihydroxyfuro[2,3-b]quinoline; o4-et,o8-me

NA

C14H13NO3 (243.0895)


{"Ingredient_id": "HBIN010139","Ingredient_name": "4,8-dihydroxyfuro[2,3-b]quinoline; o4-et,o8-me","Alias": "NA","Ingredient_formula": "C14H13NO3","Ingredient_Smile": "NA","Ingredient_weight": "243.26","OB_score": "NA","CAS_id": "105988-99-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7877","PubChem_id": "NA","DrugBank_id": "NA"}

   

methyl 4-(1h-indol-3-yl)-2-methyl-4-oxobut-2-enoate

methyl 4-(1h-indol-3-yl)-2-methyl-4-oxobut-2-enoate

C14H13NO3 (243.0895)


   

2,3,3,5-tetramethyl-2h-furo[3,2-c]quinolin-4-one

2,3,3,5-tetramethyl-2h-furo[3,2-c]quinolin-4-one

C15H17NO2 (243.1259)


   

6-benzyl-3-methoxyfuro[2,3-b]pyrrol-4-ol

6-benzyl-3-methoxyfuro[2,3-b]pyrrol-4-ol

C14H13NO3 (243.0895)


   

4-methoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

4-methoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol

C15H17NO2 (243.1259)


   

(3s)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]octanimidic acid

(3s)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]octanimidic acid

C12H21NO4 (243.1471)


   

5-[(3as,4s,6ar)-2-hydroxy-3h,3ah,4h,6h,6ah-thieno[3,4-d]imidazol-4-yl]pentanimidic acid

5-[(3as,4s,6ar)-2-hydroxy-3h,3ah,4h,6h,6ah-thieno[3,4-d]imidazol-4-yl]pentanimidic acid

C10H17N3O2S (243.1041)


   

2,2,10-trimethyl-3h,4h-pyrano[2,3-b]quinolin-5-one

2,2,10-trimethyl-3h,4h-pyrano[2,3-b]quinolin-5-one

C15H17NO2 (243.1259)


   

(2r)-2,3,3,5-tetramethyl-2h-furo[3,2-c]quinolin-4-one

(2r)-2,3,3,5-tetramethyl-2h-furo[3,2-c]quinolin-4-one

C15H17NO2 (243.1259)


   

3-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

3-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C13H13N3O2 (243.1008)


   

(1z)-2-hydroxy-1-(1h-indol-3-yl)-5-methylhex-1-en-3-one

(1z)-2-hydroxy-1-(1h-indol-3-yl)-5-methylhex-1-en-3-one

C15H17NO2 (243.1259)


   

(3s,7r)-7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

(3s,7r)-7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

C12H21NO4 (243.1471)


   

2,3,3,9-tetramethyl-2h-furo[2,3-b]quinolin-4-one

2,3,3,9-tetramethyl-2h-furo[2,3-b]quinolin-4-one

C15H17NO2 (243.1259)


   

4-hydroxy-1-methyl-3-(3-methylbut-3-en-2-yl)quinolin-2-one

4-hydroxy-1-methyl-3-(3-methylbut-3-en-2-yl)quinolin-2-one

C15H17NO2 (243.1259)


   

7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

C12H21NO4 (243.1471)


   

9-ethyl-7-methoxyfuro[2,3-b]quinolin-4-one

9-ethyl-7-methoxyfuro[2,3-b]quinolin-4-one

C14H13NO3 (243.0895)


   

methyl 1-(2-methylbut-3-en-2-yl)indole-3-carboxylate

methyl 1-(2-methylbut-3-en-2-yl)indole-3-carboxylate

C15H17NO2 (243.1259)


   

8-methoxy-4-methyl-5h-indeno[1,2-b]pyridine-5,9-diol

8-methoxy-4-methyl-5h-indeno[1,2-b]pyridine-5,9-diol

C14H13NO3 (243.0895)


   

3-{[5-(acetyloxy)-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}propanoic acid

3-{[5-(acetyloxy)-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}propanoic acid

C11H17NO5 (243.1107)


   

(5s)-5-hydroxy-5,7,7-trimethyl-6h,8h-cyclopenta[g]isoquinolin-9-one

(5s)-5-hydroxy-5,7,7-trimethyl-6h,8h-cyclopenta[g]isoquinolin-9-one

C15H17NO2 (243.1259)


   

(2s,3s,4r,5s)-2-(2-hydroxy-4-iminopyrimidin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2s,3s,4r,5s)-2-(2-hydroxy-4-iminopyrimidin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C9H13N3O5 (243.0855)


   

10-amino-7-(3-hydroxypropyl)-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,5,8(12),9-pentaen-11-one

10-amino-7-(3-hydroxypropyl)-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,5,8(12),9-pentaen-11-one

C13H13N3O2 (243.1008)


   

3-{[(2z)-5-(acetyloxy)-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}propanoic acid

3-{[(2z)-5-(acetyloxy)-1-hydroxy-3-methylpent-2-en-1-ylidene]amino}propanoic acid

C11H17NO5 (243.1107)


   

6,10-dihydroxy-3-methyl-6h,7h,8h-cyclohexa[g]isoquinolin-9-one

6,10-dihydroxy-3-methyl-6h,7h,8h-cyclohexa[g]isoquinolin-9-one

C14H13NO3 (243.0895)


   
   

2-(2-hydroxy-4-iminopyrimidin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

2-(2-hydroxy-4-iminopyrimidin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C9H13N3O5 (243.0855)


   

methyl 5-[hydroxy(phenyl)methyl]pyridine-2-carboxylate

methyl 5-[hydroxy(phenyl)methyl]pyridine-2-carboxylate

C14H13NO3 (243.0895)


   

n-({4-hydroxy-[2,2'-bipyridin]-6-yl}methyl)ethanimidic acid

n-({4-hydroxy-[2,2'-bipyridin]-6-yl}methyl)ethanimidic acid

C13H13N3O2 (243.1008)


   

5-hydroxy-5,7,7-trimethyl-6h,8h-cyclopenta[g]isoquinolin-9-one

5-hydroxy-5,7,7-trimethyl-6h,8h-cyclopenta[g]isoquinolin-9-one

C15H17NO2 (243.1259)


   

(5r)-8-methoxy-4-methyl-5h-indeno[1,2-b]pyridine-5,9-diol

(5r)-8-methoxy-4-methyl-5h-indeno[1,2-b]pyridine-5,9-diol

C14H13NO3 (243.0895)


   

(5r,5as)-5-hydroxy-5,7,7-trimethyl-5ah,6h-cyclopenta[g]isoquinolin-9-one

(5r,5as)-5-hydroxy-5,7,7-trimethyl-5ah,6h-cyclopenta[g]isoquinolin-9-one

C15H17NO2 (243.1259)


   

(2s)-1-(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}acetyl)pyrrolidine-2-carboxylic acid

(2s)-1-(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}acetyl)pyrrolidine-2-carboxylic acid

C10H17N3O4 (243.1219)


   

methyl 5-[(r)-hydroxy(phenyl)methyl]pyridine-2-carboxylate

methyl 5-[(r)-hydroxy(phenyl)methyl]pyridine-2-carboxylate

C14H13NO3 (243.0895)


   

methyl (2e)-4-(1h-indol-3-yl)-2-methyl-4-oxobut-2-enoate

methyl (2e)-4-(1h-indol-3-yl)-2-methyl-4-oxobut-2-enoate

C14H13NO3 (243.0895)


   

4'-hydroxy-6-methoxy-[1,1'-biphenyl]-3-carboximidic acid

4'-hydroxy-6-methoxy-[1,1'-biphenyl]-3-carboximidic acid

C14H13NO3 (243.0895)


   

(e)-methoxy({4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)amine

(e)-methoxy({4-methoxy-[2,2'-bipyridin]-6-yl}methylidene)amine

C13H13N3O2 (243.1008)


   

5-hydroxy-5,7,7-trimethyl-5ah,6h-cyclopenta[g]isoquinolin-9-one

5-hydroxy-5,7,7-trimethyl-5ah,6h-cyclopenta[g]isoquinolin-9-one

C15H17NO2 (243.1259)


   

(6s)-6,10-dihydroxy-3-methyl-6h,7h,8h-cyclohexa[g]isoquinolin-9-one

(6s)-6,10-dihydroxy-3-methyl-6h,7h,8h-cyclohexa[g]isoquinolin-9-one

C14H13NO3 (243.0895)